MediPal Holdings Corporation Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Earnings Guidance for the Year Ending March 31, 2017
August 04, 2016 at 04:18 pm
Share
MediPal Holdings Corporation announced consolidated earnings results for the first quarter ended June 30, 2016. For the quarter, the company reported net sales of ¥771.6 billion against ¥742.3 billion a year ago. Operating income was ¥11.6 billion against ¥8.1 billion a year ago. Ordinary income was ¥14.9 billion against ¥11.1 billion a year ago. Net income attributable to owners of the parent was ¥8.4 billion against ¥5.3 billion a year ago.
For the year ending March 31, 2017, the company expects net sales of ¥3,103.0 billion, gross profit of ¥225.5 billion, operating income of ¥42.5 billion, ordinary income of ¥55.5 billion, and net income attributable to owners of the parent of ¥31.0 billion.
MEDIPAL HOLDINGS CORPORATION engages in the wholesale of pharmaceutical products, cosmetics and daily miscellaneous goods. The Company operates in three segments. The Ethical Pharmaceutical Wholesale segment is involved in the wholesale of pharmaceutical products, medical equipment and test reagents, the distribution and planning of specialty drugs, the construction of medical material database and others. The Cosmetics, Daily Product and General Medicine Wholesale segment is engaged in the wholesale of cosmetics, daily miscellaneous goods and general pharmaceuticals. The Veterinary Medicine and Food Processing Raw Materials Wholesale segment is engaged in the wholesale of veterinary products, food additives and food raw materials. The Company is also involved in the provision of cleaning services, the management and operation of logistics centers, the provision of manpower dispatching services and others.
MediPal Holdings Corporation Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Earnings Guidance for the Year Ending March 31, 2017
MEDIPAL HOLDINGS CORPORATION 
